Friday, 16 April, 2021

Top EMA Official Links AstraZeneca Vaccine To Blood Clots | IE

The EMA's safety committee'has not yet reached a conclusion and the review is currently ongoing The EMA's safety committee'has not yet reached a conclusion and the review is currently ongoing, Premium
Cecil Davis | 06 April, 2021, 19:36

"In my opinion, we can say it now, it is clear there is a link with the vaccine", said the EMA's head of vaccines Marco Cavaleri in an interview with Italy's Il Messaggero newspaper.

Today's news contrasts starkly with the EMA's statement that was published on March 11, which stated that AstraZeneca's COVID-19 vaccine showed no direct links to blood clots.

Cavaleri added that the EMA would say there is a link although the regulator would not likely be in a position this week to give an indication regarding the age of individuals to whom the AstraZeneca shot should be given.

A heath chief from the European Medicines Agency (EMA) has said that there is a link between AstraZeneca's Covid-19 vaccine and blood clots. "But we still do not know what causes this reaction".

Australia began vaccinations much later than some other countries due to low case numbers, recording just under 29,400 COVID-19 cases and 909 deaths since the pandemic began.

Scientists are exploring several possibilities that might explain the extremely rare brain blood clots that occurred in individuals in the days and weeks after receiving the AstraZeneca vaccine.

When can I register online for the COVID-19 vaccine in BC?
You will also be asked to provide an email address that gets checked regularly or a phone number that can receive texts. To register you will need to provide your name, date of birth, postal code, and Personal Health Number.

However, the EMA then conducted an investigation into the vaccine, and found that the benefits outweigh the risks and it should continue to be used.

Authorities had pledged to administer at least 4 million first doses of the vaccine by end-March, but could only vaccinate 670,000 after the European Union blocked AstraZeneca vaccine exports to Australia in the wake of the drugmaker's failure to meet its shipment pledge to the bloc.

An investigation is also underway in the United Kingdom, where researchers are looking at the possibility of links between the AstraZeneca vaccine and rare blood clots.

Twomey also blamed the slow rollout on a lack of co-ordination between the Australian national government and states, with the latter complaining about slower-than-expected distribution and a lack of certainty on vaccine supplies.

The EMA last week recommended that countries should keep using the AstraZeneca vaccine because the benefits outweighed the risks, as countries including Italy suspended their rollout of the jab.